The association of solid-phase assays to immunofluorescence increases the diagnostic accuracy for ANA screening in patients with autoimmune rheumatic diseases

Autoimmun Rev. 2018 Jun;17(6):541-547. doi: 10.1016/j.autrev.2017.12.007. Epub 2018 Apr 7.
No abstract available

Keywords: ANA; Antinuclear antibodies; CTD screen; Immunofluorescence; Solid-phase assay.

Publication types

  • Multicenter Study

MeSH terms

  • Antibodies, Antinuclear / blood*
  • Autoimmune Diseases / blood
  • Autoimmune Diseases / diagnosis*
  • Cell Line, Tumor
  • Cost-Benefit Analysis
  • Female
  • Fluorescent Antibody Technique
  • Fluorescent Antibody Technique, Indirect
  • Humans
  • Immunoassay / economics
  • Immunoassay / methods*
  • Male
  • Middle Aged
  • Rheumatic Diseases / blood
  • Rheumatic Diseases / diagnosis*
  • Sensitivity and Specificity

Substances

  • Antibodies, Antinuclear